acquired
Stage
1
Investors
About
Swift Biosciences developed and sold next-generation sequencing (NGS) library preparation kits and reagents for research and clinical genomics. The company was acquired by Integrated DNA Technologies in March 2021.
Explore Swift Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.